On a Thursday in mid-June, Dr. David Bomback scrubbed-in for surgery and prepared to do what no Connecticut surgeon had done before. He was performing a groundbreaking lower-back surgery on 36-year-old Joe Esposito, a physical therapist from Sandy Hook, to insert a new device that could help prevent Esposito’s spinal disk from re-herniating. The lower-back […]
Read moreIn the News
Stanford Health Care – ValleyCare first in state to use new device to prevent reherniated spinal discs
News“A middle school teacher is relieved of crippling back pain after Stanford surgeons implant a device to prevent a herniated spinal disc from recurring.” Read the full article at Stanford Medicine News Center.
Read moreVA Adds C9757 Code to 2021 Fee Schedule
NewsIntrinsic Therapeutics is proud to announce that the US Veterans Administration (VA) has officially added the (Barricaid Implantation) HCPCS code C9757 to their 2021 national outpatient fee schedule – effective January 1, 2021.¹ The VA is the 2nd largest government-funded health insurance organization in the U.S. with approximately 9 million covered lives. The Barricaid, a […]
Read moreA Level IA Expert Review and Meta-Analysis Provides Support for the Adoption of Barricaid in Well-Selected Patients Undergoing Lumbar Discectomy for Lumbar Disc Herniation
NewsThe importance of a cost-effective treatment option for patients with large annular defects is underscored by a recently published Level IA expert review and meta-analysis of four comparative studies (n=801 patients) including two randomized controlled trials involving more than 600 patients. In this review, the authors (L Miller, R Todd Allen, B Duhon, K Radcliff) […]
Read moreSurgeons and Spine Societies Increase Patient Access to Barricaid® for Discectomy Surgery Following Recent Coding Successes and Recognition in Updated Guidelines
Press ReleaseIntrinsic Therapeutics Offers Virtual and Hands-On Training Sessions as Elective Surgeries Resume – via PR Newswire WOBURN, Mass., June 2, 2020 – Intrinsic Therapeutics, Inc., a medical device company focused on delivering safe treatments to improve surgical efficacy, today announced growing enthusiasm among physicians for its Barricaid technology, which manages lumbar disc herniation. While elective […]
Read moreCOVID-19 Company Update
Company Update“The measure of intelligence is the ability to change.” ― Albert Einstein. While this unprecedented time has forced us all to make changes and sacrifices, the Intrinsic team is using the time to learn and adopt innovative ways to educate and train the medical and patient communities on the impact Barricaid can have in managing lumbar […]
Read moreAnnular Closure a Key Topic in latest Int Journal of Spine Surgery
Barricaid and the topic of annular closure for herniated disc patients feature in two articles in the most recent issue by IJSS, the International Journal of Spine Surgery. This journal is the official publication of ISASS, the International Society for the Advancement of Spine Surgery. ISASS is among the largest societies of spine surgeons, and […]
Read more“Annular repair and the field of disc biology” named critical area for advancement, Becker’s Spine
This week, in a conversation with Becker’s Healthcare, Dr. Andrew Hecht (MD, Mt. Sinai Hospital, New York City) named “annular repair and the field of disc biology” one of the next big trends in spine. Barricaid is designed to close large annular holes, thereby reducing reherniation rates in patients at higher risk. Thank you, Dr. […]
Read moreRecap of a successful inaugural U.S. Disc Collective Meeting
Press ReleaseNew York NY, January 2020 – Intrinsic Therapeutics hosted its first U.S. Disc Collective Meeting on 16-17 January, 2020 in Manhattan, New York. 15 spine surgeons travelled to the East Coast in order to learn more about and exchange experiences on the topic of lumbar disc herniation. The program was themed around “A future of […]
Read moreBarricaid maker Intrinsic Therapeutics among top 20 private medtech companies
NewsThe Barricaid team is proud to be ranked among the top 20 private medtech companies to watch in 2020 by MDDI (Medical Device and Diagnostic Industry). To our mission, we stay committed to reducing needless suffering by ensuring Barricaid Annular Closure is accessible to patients and surgeons. Intrinsic Therapeutics’ Barricaid device is the only FDA […]
Read more